ECCMID 2021 is over, but you can still watch top ARLG leaders and experts discuss the latest AMR topics on demand! Use the guide below to choose your favorite conference sessions and get on demand access here.
| Day | Time (CEST) | Session #, Session Title, and Presentation Title | Chair and Speakers |
|---|---|---|---|
| July 9 | 10:45-12:15 | S48- Multidisciplinary science underpins antimicrobial stewardship | Minggui Wang, Chair |
| July 10 | 8:30-9:30 | 2573- New antibiotics in the pipeline and on the market: more of the same or real innovations? Market entries in 2020 and 2021: which new antibiotics did we get? | David Paterson, Speaker |
| July 10 | 15:30-17:00 | 2767- COVID-19 in special populations | Souha Kanj, Chair |
| July 10 | 17:15-18:15 | S27- New targets, new drugs, new strategies against highly resistant bacteria | Mariana Castanheira, Chair |
| July 10 | 19:15-20:45 | 2389- Hot topics in transplant ID | David van Duin, Chair |
| July 10 | 19:15-20:45 | S182- Late breaking clinical trial data | David Paterson, Chair |
| July 11 | 9:30-10:30 | S39- Genomic epidemiology and resistome analysis Prevalence of colistin heteroresistance in patients with carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes | Jessica Howard-Anderson, Speaker |
| July 11 | 15:30-17:00 | S102- COVID-19: impact on healthcare workers and transmission risk | Yehuda Carmeli, Chair |
| July 12 | 13:15-14:45 | 2549- Beta-lactam/beta-lactamase inhibitor combinations Old and new BLIs compared | Robert Bonomo, Chair |
| July 12 | 13:15-14:45 | S127- Clostridioides difficile infection: painting a picture of prediction and prevention | Deverick Anderson, Chair |
| July 12 | 13:15-15:15 | Clinical Grand Rounds 2021 | Helen Boucher, Speaker; Souha Kanj, Speaker; David Paterson, Speaker |
| July 12 | 17:15-18:15 | 5010- Publishing in clinical microbiology and infectious diseases: 5-10 years outlook | Robert Schooley, Chair |
| July 12 | 17:15-18:15 | 2250- Meet-the Expert Session: How I treat highly resistant Gram-negative bacterial infections | David van Duin, Speaker |
| July 12 | 17:15-18:15 | 2313 Can pharma companies contribute effectively to the stewardship of new antibiotics? Yes, they can! | Helen Boucher, Speaker |
| July 12 | 19:15-20:45 | 2722 Antimicrobial stewardship in COVID times: a challenge within a challenge AMS in COVID times: role for biomarkers/rapid diagnostics to reduce inappropriate use | Larissa May, Speaker |